Latest Insider Transactions at Verona Pharma PLC (VRNA)
This section provides a real-time view of insider transactions for Verona Pharma PLC (VRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Verona Pharma plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Verona Pharma plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
183,728
-1.36%
|
$918,640
$5.01 P/Share
|
|
Dec 06
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
162,800
-1.13%
|
$814,000
$5.01 P/Share
|
|
Dec 05
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
640,048
-4.53%
|
$3,200,240
$5.01 P/Share
|
|
Dec 05
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
640,264
-4.27%
|
$3,201,320
$5.01 P/Share
|
|
Dec 04
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
58,184
-0.41%
|
$290,920
$5.0 P/Share
|
|
Dec 04
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
67,608
-0.45%
|
$338,040
$5.0 P/Share
|
|
Dec 02
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,600
-0.01%
|
$8,000
$5.0 P/Share
|
|
Dec 02
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
3,200
-0.02%
|
$16,000
$5.0 P/Share
|
|
Nov 29
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
98,704
-0.69%
|
$493,520
$5.01 P/Share
|
|
Nov 29
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
98,888
-0.65%
|
$494,440
$5.01 P/Share
|
|
Nov 27
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,936
-0.09%
|
$64,680
$5.0 P/Share
|
|
Nov 27
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
23,240
-0.15%
|
$116,200
$5.0 P/Share
|
|
Nov 26
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
800
-0.01%
|
$4,000
$5.0 P/Share
|
|
Nov 25
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
1,600
-0.01%
|
$8,000
$5.0 P/Share
|
|
Nov 25
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,600
-0.01%
|
$8,000
$5.0 P/Share
|
|
Nov 25
2024
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
240,000
-8.24%
|
$960,000
$4.9 P/Share
|
|
Nov 18
2024
|
David R Ebsworth Director |
BUY
Open market or private purchase
|
Direct |
20,000
+2.08%
|
$80,000
$4.44 P/Share
|
|
Nov 11
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,400
-0.02%
|
$12,000
$5.0 P/Share
|
|
Nov 11
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
2,400
-0.02%
|
$12,000
$5.0 P/Share
|
|
Nov 06
2024
|
Christina Ackermann Director |
BUY
Open market or private purchase
|
Direct |
41,880
+50.0%
|
$167,520
$4.74 P/Share
|
|
Nov 06
2024
|
David R Ebsworth Director |
BUY
Open market or private purchase
|
Direct |
39,360
+4.1%
|
$157,440
$4.8 P/Share
|
|
Nov 04
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
80,784
-0.56%
|
$323,136
$4.39 P/Share
|
|
Nov 04
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
94,144
-0.62%
|
$376,576
$4.39 P/Share
|
|
Nov 01
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
48,888
-0.34%
|
$195,552
$4.38 P/Share
|
|
Nov 01
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
46,888
-0.31%
|
$187,552
$4.38 P/Share
|
|
Nov 01
2024
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
245,952
-1.58%
|
$983,808
$4.24 P/Share
|
|
Nov 01
2024
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+1.27%
|
-
|
|
Nov 01
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
245,952
-1.68%
|
$983,808
$4.24 P/Share
|
|
Nov 01
2024
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+1.35%
|
-
|
|
Nov 01
2024
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
65,936
-2.21%
|
$263,744
$4.24 P/Share
|
|
Nov 01
2024
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+1.65%
|
-
|
|
Oct 30
2024
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+4.94%
|
-
|
|
Oct 30
2024
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+5.24%
|
-
|
|
Oct 30
2024
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+9.3%
|
-
|
|
Oct 30
2024
|
Andrew Fisher General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Oct 25
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
4,800
-0.03%
|
$19,200
$4.38 P/Share
|
|
Oct 25
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,200
-0.02%
|
$12,800
$4.38 P/Share
|
|
Oct 24
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
140,000
-0.95%
|
$560,000
$4.38 P/Share
|
|
Oct 24
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
141,360
-1.02%
|
$565,440
$4.38 P/Share
|
|
Oct 23
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
16
-0.0%
|
$64
$4.38 P/Share
|
|
Oct 22
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
159,344
-1.14%
|
$637,376
$4.38 P/Share
|
|
Oct 22
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
157,912
-1.06%
|
$631,648
$4.39 P/Share
|
|
Oct 21
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
116,696
-0.83%
|
$466,784
$4.38 P/Share
|
|
Oct 21
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
110,456
-0.74%
|
$441,824
$4.38 P/Share
|
|
Oct 18
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
249,728
-1.74%
|
$998,912
$4.38 P/Share
|
|
Oct 18
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
245,784
-1.61%
|
$983,136
$4.38 P/Share
|
|
Sep 11
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600,000
-4.02%
|
$1,800,000
$3.76 P/Share
|
|
Sep 11
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
600,000
-3.79%
|
$1,800,000
$3.76 P/Share
|
|
Aug 13
2024
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
398,400
-1.3%
|
$1,195,200
$3.23 P/Share
|
|
Aug 13
2024
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
398,400
-1.23%
|
$1,195,200
$3.23 P/Share
|